Table 1.

Clinicopathologic features of two cohorts of patients with bladder cancer

CharacteristicsN = 101 patients, no. cases (%)N = 28 patients, no. cases (%)
Age (y)
    Median (range)70 (42-89)67 (38-95)
Sex
    Male81 (80.2)21 (75.0)
    Female20 (19.8)7 (25.0)
Pathologic stage
    pTa012 (42.9)
    pT171 (70.3)8 (28.5)
    pT213 (12.8)4 (14.3)
    pT317 (16.8)4 (14.3)
pT1 subclassification
    pT1a46 (64.8)Not determined
    pT1b25 (35.2)Not determined
Pathologic stage/histologic grade
    pTa
        1973 WHO
            G109 (75.0)
            G203 (25.0)
        2004 WHO
            Low malignant potential02 (16.7)
            Low grade010 (83.3)
    pT1
        1973 WHO
            G13 (4.2)0
            G230 (42.3)4 (50.0)
            G338 (53.5)4 (50.0)
        2004 WHO
            Low grade14 (19.7)5 (62.5)
            High grade57 (80.3)3 (37.5)
    pT2
        1973 WHO
            G24 (30.8)0
            G39 (69.2)4 (100)
        2004 WHO
            High grade13 (100)4 (100)
    pT3
        1973 WHO
            G21 (5.9)0
            G316 (94.1)4 (100)
        2004 WHO
            High grade17 (100)4 (100)
pTa/carcinoma in situ
    No012 (100)
pT1/carcinoma in situ
    No39 (55.0)7 (87.5)
    Yes32 (45.0)1 (12.5)
pT2/carcinoma in situ
    No8 (61.5)3 (75.0)
    Yes5 (38.5)1 (25.0)
pT3/carcinoma in situ
No13 (76.5)3 (75.0)
Yes4 (23.5)1 (25.0)